Necrotising myositis – Life with Disease

Go back

Necrotising myositis is a rare muscle disease that causes the death of muscle cells, leading to severe weakness, difficulty climbing stairs, and challenges with everyday movements. Although there is no cure, understanding the disease, its natural progression, and the complications it may bring can help patients and families prepare for the journey ahead.

Understanding the Prognosis of Necrotising Myositis

Learning that you have necrotising myositis—also known as immune-mediated necrotising myopathy or IMNM—can feel overwhelming and deeply frightening. It’s natural to want to know what the future holds, and it’s important to approach this question with both honesty and hope. Prognosis, which means the expected course and outcome of a disease, varies significantly from person to person with necrotising myositis.[1][2]

Necrotising myositis is a condition in which muscle cells die rather than simply becoming inflamed. This process, called necrosis, leads to severe muscle weakness that can develop over just days, weeks, or months. The disease primarily affects muscles near the center of the body—the shoulders, upper arms, hips, thighs, neck, and back—making ordinary tasks like climbing stairs, lifting objects, or even brushing your hair feel impossibly difficult.[1][3]

The outlook for people with necrotising myositis depends on several factors. One major factor is the type of autoantibodies—proteins produced by the immune system—found in the blood. There are three recognized subtypes: those with anti-SRP autoantibodies, those with anti-HMGCR autoantibodies, and those without either of these markers. Patients with anti-SRP antibodies often experience more severe muscle involvement, with significant weakness and sometimes difficulty swallowing. They may also have inflammation in the lungs or heart, which adds complexity to their condition.[1][2]

Anti-HMGCR positive necrotising myositis, often associated with statin medications used to lower cholesterol, typically presents with mainly severe muscle symptoms but less involvement of other organs. While this may sound reassuring, the muscle weakness itself can be profound and disabling.[1][10]

Age at diagnosis also plays an important role in prognosis. Younger patients—including children—tend to experience more severe disease that can be harder to treat. In some cases, children may present with features that resemble muscular dystrophy, though these may be potentially reversible with aggressive treatment. This is deeply distressing for families, yet it underscores the importance of early and intensive therapy.[2][9]

The response to treatment is another critical element. Some patients respond well to immune-suppressing medications, intravenous immunoglobulin (IVIG), or therapies like rituximab, while others have more resistant disease. Unfortunately, many people with necrotising myositis require long-term combination therapy and experience relapses when medications are reduced or stopped.[9][11]

⚠️ Important
Early and aggressive treatment is crucial in necrotising myositis. Muscle cells can undergo fatty replacement soon after disease onset, which means that the longer the disease goes untreated, the less likely muscles are to recover fully. This is why prompt diagnosis and starting therapy as soon as possible may provide the best chance to avoid long-term disability.[2][9]

While many patients live for many years after diagnosis and can manage their symptoms with ongoing care, it’s also true that necrotising myositis can be very serious. Some patients were historically told that the disease carried a high mortality rate, especially in those with anti-SRP antibodies. However, with improved understanding of the disease and better treatment options, more people are living successfully with necrotising myositis for many years.[14]

How the Disease Progresses Without Treatment

Understanding the natural progression of necrotising myositis—what happens if the disease is left untreated—can help patients and families grasp the importance of medical care. Without treatment, necrotising myositis does not improve on its own. The immune system continues to attack and destroy muscle cells, leading to worsening weakness over time.[2][3]

In the beginning, a person may notice subtle changes. Tasks that once felt easy—riding a bicycle, climbing stairs, standing up from a chair—may become surprisingly difficult or even impossible. The weakness is typically symmetrical, meaning it affects both sides of the body equally. Over time, this weakness can spread and intensify, affecting the ability to lift the arms overhead, grip objects firmly, or walk without falling.[1][5]

As muscle cells die and are not replaced, the muscles themselves can shrink and weaken permanently. In some cases, dead muscle tissue is replaced by fat, a process that can be seen on imaging scans. Once this fatty replacement occurs, the damage is often irreversible, even with treatment. This makes early intervention critically important.[2][9]

Without therapy, some patients may progress to the point where they are unable to care for themselves. They may lose the ability to walk, to bathe or dress independently, or to hold utensils or write. In the most severe, untreated cases, muscles that control breathing or swallowing may also be affected, leading to life-threatening complications such as respiratory failure or aspiration pneumonia (when food or liquids enter the lungs).[3][15]

The disease may also have periods of apparent stability followed by sudden worsening, sometimes triggered by illness, stress, or unknown factors. This unpredictability can be deeply unsettling and underscores the need for continuous monitoring and treatment adjustments.[15]

Possible Complications of Necrotising Myositis

Necrotising myositis can lead to a range of complications beyond muscle weakness. These complications can affect quality of life and, in some cases, become serious threats to health. Understanding these risks can help patients and their families stay vigilant and seek help promptly when new symptoms arise.[3][15]

One of the most concerning complications is dysphagia, or difficulty swallowing. This happens when the muscles of the throat and esophagus (the tube that carries food to the stomach) become weak. Swallowing problems can lead to choking, poor nutrition, weight loss, and dehydration. More seriously, food or liquids may enter the lungs instead of the stomach, a condition called pulmonary aspiration. This can cause irritation, infection, and pneumonia, which can be life-threatening.[1][15]

Breathing difficulties are another significant risk. When the muscles of the chest and diaphragm (the main muscle used for breathing) weaken, a person may experience hypoventilation, which means they cannot breathe deeply enough. This leads to low oxygen levels and a buildup of carbon dioxide in the blood. Patients may feel short of breath, especially when lying down or during exertion. In severe cases, respiratory failure can occur, requiring emergency medical care and possibly mechanical ventilation.[5][15]

Patients with anti-SRP antibodies may also develop inflammation in the lungs, known as interstitial lung disease, or inflammation of the heart muscle. These complications can cause chest pain, persistent coughing, shortness of breath, and fatigue. They require careful monitoring and treatment by specialists.[1][2]

Necrotising myositis may also increase the risk of falls and injuries. Weak muscles, especially in the legs and core, make it hard to balance and recover from stumbles. Falls can lead to fractures, head injuries, and a loss of confidence in moving around safely. Some people may become fearful of walking and begin to avoid activity, which can worsen muscle weakness and overall health.[5][14]

There is also a potential link between necrotising myositis and cancer. Although the connection is not fully understood, some patients may develop cancer before, during, or after their myositis diagnosis. Doctors often recommend screening for cancer, especially in older adults or those with certain risk factors.[5][8]

Long-term use of medications to suppress the immune system—necessary to control the disease—can also lead to complications. These may include increased risk of infections, bone thinning (osteoporosis), weight gain, high blood pressure, diabetes, and mood changes. Balancing the benefits of treatment with these side effects is a constant challenge for patients and their doctors.[12][19]

How Necrotising Myositis Affects Daily Life

Living with necrotising myositis means adapting to a new reality where the body no longer responds the way it once did. The impact of this disease reaches into nearly every aspect of daily life—physically, emotionally, socially, and even financially.[14][15]

Physically, the muscle weakness caused by necrotising myositis makes even simple tasks exhausting or impossible. Getting dressed, preparing a meal, carrying groceries, or opening jars can become monumental challenges. Many patients need help with bathing, grooming, and toileting, which can be deeply distressing and can affect their sense of independence and dignity.[5][14]

Mobility is often severely affected. Walking may become slow and unsteady, and many patients rely on canes, walkers, wheelchairs, or scooters to get around. Driving may no longer be safe, which can lead to isolation and dependence on others for transportation. Work may become impossible, especially for those in physically demanding jobs, leading to financial stress and loss of professional identity.[14][18]

Emotionally, necrotising myositis can be devastating. Many patients describe feelings of grief, frustration, anger, and sadness. The loss of abilities that were once taken for granted—like playing with children, gardening, dancing, or exercising—can feel like losing a part of oneself. The unpredictability of the disease, with periods of stability interrupted by sudden flares, creates a constant sense of uncertainty and fear about the future.[14][18]

Social relationships can also suffer. Friends and family members may not understand the severity or invisibility of the disease, leading to feelings of isolation and misunderstanding. Some people withdraw from social activities because they are embarrassed by their physical limitations or because they simply don’t have the energy. The strain on marriages and family relationships can be significant, as loved ones take on new roles as caregivers.[15][18]

Despite these challenges, many patients find ways to adapt and maintain a sense of purpose and joy. Some learn to ask for help, use assistive devices, and pace themselves to conserve energy. Others find new hobbies or activities that are less physically demanding. Physical therapy and occupational therapy can teach strategies to make daily tasks easier and safer.[12][16]

Staying as active as possible is important, even if that means only gentle stretching or short walks. Exercise is considered beneficial for myositis patients, as it can help maintain muscle strength, prevent stiffness, and improve mood. However, it’s important to work with a physical therapist to design a safe and appropriate exercise program.[16][18]

Nutrition also plays a role in managing daily life with necrotising myositis. A well-balanced diet can support overall health, maintain a healthy weight, and provide the energy needed to cope with the disease. Some patients may need to modify the texture of their food if they have swallowing difficulties.[16]

Managing stress is another important aspect of coping. Chronic illness brings stress, and stress can worsen symptoms and trigger flares. Finding healthy outlets—whether through relaxation techniques, gentle exercise like yoga, biofeedback, meditation, or connecting with others who understand the disease—can make a meaningful difference.[16][18]

⚠️ Important
The first year after diagnosis is often the hardest. Patients are adjusting to a new normal, learning about their disease, and finding the right treatment. It’s important to be patient with yourself and not give up. Many people find that with time, support, and the right care, they can live meaningful and fulfilling lives despite the challenges of necrotising myositis.[18]

Support for Families: Understanding Clinical Trials and How to Help

When a loved one is diagnosed with necrotising myositis, families often feel helpless and desperate to do something—anything—to help. One of the most valuable ways family members can support a patient is by learning about clinical trials and helping the patient explore whether participation might be an option.[14]

Clinical trials are research studies that test new treatments, medications, or approaches to managing disease. For rare diseases like necrotising myositis, clinical trials are essential. They help scientists and doctors understand the disease better, discover what treatments work, and improve outcomes for future patients. Participating in a clinical trial also gives patients access to cutting-edge therapies that are not yet widely available.[14]

However, understanding clinical trials can be confusing, and many patients don’t know where to start. This is where families can step in. Relatives can help by researching ongoing trials, which can be found through resources like clinical trial registries, patient organizations such as The Myositis Association, or by asking the patient’s doctor for information. Some patients are too tired, overwhelmed, or discouraged to do this research themselves, so having a family member take the lead can make a real difference.[14]

Families can also help by organizing medical information. Clinical trial applications often require detailed medical records, test results, and a list of medications. Creating a medical binder—a well-organized collection of all this information—makes it much easier for the patient to enroll in a trial or even just go to doctor appointments. This binder might include visit summaries, lab results, imaging reports, a list of current and past medications, and a list of symptoms and how they change over time.[18]

It’s also helpful for families to accompany the patient to medical appointments, especially when clinical trial participation is being discussed. Having an extra set of ears can ensure that important information isn’t missed, and family members can help ask questions or advocate for the patient’s needs.[18]

Beyond clinical trials, there are many other practical ways families can support someone with necrotising myositis. Offering to help with daily tasks—cooking, cleaning, running errands, driving to appointments—can ease the burden on the patient. Emotional support is equally important. Simply listening, offering encouragement, and being present can make a huge difference. Chronic illness can be lonely and isolating, and knowing that someone cares and understands can provide comfort and hope.[18]

Families should also educate themselves about necrotising myositis. Reliable sources of information include patient organizations, medical websites, and educational materials provided by specialists. Avoid relying solely on internet search engines, which may provide outdated or inaccurate information that can be frightening and misleading.[18]

Finally, families should remember to take care of themselves. Caring for someone with a chronic, debilitating illness is exhausting and emotionally draining. Caregivers need support too, whether through support groups, counseling, respite care, or simply making time for their own health and well-being. Taking care of yourself is not selfish—it’s necessary in order to continue providing the best care for your loved one.[18]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Prednisone (Glucocorticoid) – A corticosteroid used to reduce inflammation and suppress the immune system’s attack on muscle tissue.
  • Azathioprine – An immunosuppressive drug used to help control the immune response and manage symptoms.
  • Methotrexate – An immunosuppressive medication used to reduce inflammation and slow disease progression.
  • Mycophenolate mofetil (CellCept) – An immunosuppressant used to help control the autoimmune process in necrotising myositis.
  • Tacrolimus – An immunosuppressive agent used to manage the disease.
  • Cyclosporine – An immunosuppressive drug used to reduce immune system activity.
  • Intravenous Immunoglobulin (IVIG) – A blood product used to modulate the immune system and treat muscle inflammation.
  • Rituximab – A monoclonal antibody that targets certain immune cells and is used to treat severe or resistant cases.

Ongoing Clinical Trials on Necrotising myositis

References

https://www.myositis.org/about-myositis/types-of-myositis/necrotizing-myopathy/

https://pmc.ncbi.nlm.nih.gov/articles/PMC6019613/

https://www.mda.org/disease/immune-mediated-necrotizing-myopathy

https://pmc.ncbi.nlm.nih.gov/articles/PMC2658222/

https://ameripharmaspecialty.com/other-health-conditions/necrotizing-myopathy/

https://myositis.org.au/myositis/necrotising-myositis/

https://openneurologyjournal.com/VOLUME/18/ELOCATOR/e1874205X278676/FULLTEXT/

https://www.myositis.org.uk/2022/09/09/what-is-immune-mediated-necrotising-myopathy/

https://pmc.ncbi.nlm.nih.gov/articles/PMC8378663/

https://www.myositis.org/about-myositis/types-of-myositis/necrotizing-myopathy/

https://pubmed.ncbi.nlm.nih.gov/34422547/

https://www.mda.org/disease/immune-mediated-necrotizing-myopathy/medical-management

https://ameripharmaspecialty.com/other-health-conditions/necrotizing-myopathy/

https://www.myositis.org/blog/my-journey-with-necrotizing-myopathy/

https://myacare.com/blog/living-with-myositis-how-to-cope-with-muscle-inflammation

https://www.hopkinsmyositis.org/unique/treatment-myositis/

https://ameripharmaspecialty.com/other-health-conditions/necrotizing-myopathy/

https://www.myositis.org/blog/shawnas-top-10-tips-for-the-newly-diagnosed/

https://www.mda.org/disease/immune-mediated-necrotizing-myopathy/medical-management

https://www.hss.edu/health-library/conditions-and-treatments/list/myositis

https://understandingmyositis.org/myositis/necrotizing-autoimmune-myopathy/

FAQ

Is necrotising myositis fatal?

Necrotising myositis can be serious and, in the past, was associated with high mortality rates, especially in patients with anti-SRP antibodies. However, with improved understanding and better treatment options, many people now live for many years after diagnosis. The key is early diagnosis and aggressive treatment to prevent complications such as respiratory failure or aspiration pneumonia.[14][15]

Can you recover from necrotising myositis?

There is no cure for necrotising myositis, but many patients can achieve symptom control and stability with ongoing treatment. Some patients experience significant improvement in muscle strength with immunosuppressive therapy, though recovery is often incomplete, especially if fatty replacement of muscle has already occurred. Early and aggressive treatment offers the best chance for recovery.[9][11]

Is necrotising myositis painful?

Muscle pain is not always a prominent symptom of necrotising myositis. The main symptom is muscle weakness. However, some patients do experience muscle pain, tenderness, fatigue, and a general feeling of discomfort. The experience varies from person to person.[5][15]

How is necrotising myositis diagnosed?

Diagnosis involves a combination of clinical evaluation, blood tests to detect specific autoantibodies (anti-SRP or anti-HMGCR), muscle biopsy showing necrosis with minimal inflammation, and sometimes imaging or electromyography (EMG) to assess muscle damage. Since the disease is rare, many patients need to see a specialist familiar with myositis for an accurate diagnosis.[1][3]

What triggers a flare-up in necrotising myositis?

Flares—periods when symptoms suddenly worsen—can be triggered by a variety of factors, including illness, stress, bad weather, poor diet, fatigue, or sometimes no identifiable cause. Keeping a symptom journal and working closely with your doctor can help identify and avoid your personal triggers.[14][15]

🎯 Key takeaways

  • Necrotising myositis causes severe muscle weakness due to muscle cell death, primarily affecting muscles close to the body’s center.
  • The disease has three subtypes based on autoantibodies: anti-SRP, anti-HMGCR, and seronegative, each with different prognosis and treatment approaches.
  • Early and aggressive treatment is critical to prevent irreversible muscle damage caused by fatty replacement.
  • Younger patients, including children, may experience more severe disease and require intensive therapy.
  • Complications can include difficulty swallowing, breathing problems, falls, and increased risk of cancer.
  • Many patients require long-term combination therapy and may relapse when medications are tapered.
  • The first year after diagnosis is often the hardest, but with time, support, and proper care, many people live meaningful lives.
  • Family members can provide invaluable support by helping with clinical trial research, organizing medical records, and offering emotional and practical assistance.